Industry-Sponsored Satellite Symposium (nonaccredited)

Wednesday, April 26, 2023
Lunch and Check in: 11:30–11:45 a.m.
Program: 11:45 a.m.–12:45 p.m.

Although not directly affiliated with the Medical Director and Clinician Leadership Forum, we hope you attend and support this additional opportunity. There is no separate registration fee to attend.

Venclexta® (Venetoclax Tablets) Long-Term Data, RWE, and Cost Considerations

This talk will provide an overview of the disease state, goals of treatment, and patient management considerations. It will discuss clinical and health-economic data for Venclexta® (venetoclax tablets) including long-term efficacy, safety, real-world data, cost of treatment sequences, and total cost of care. 

Speaker: Dr. Bita Fakhri is an Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, and other hematologic malignancies. As a clinical scientist, Dr. Fakhri is dedicated to caring for patients, teaching trainees, and researching novel therapies for patients with CLL/SLL. Dr. Fakhri has co-authored numerous publications on topics including CLL, novel targeted agents, and cellular therapies for patients with hematologic malignancies. Currently, Dr. Fakhri is the director of the CLL clinical trial portfolio at Stanford, and serves on the National Comprehensive Cancer Network CLL panel.

This symposium is sponsored by AbbVie US Medical Affairs. This symposium is restricted to the US Healthcare Decision Makers only.

*

Attendee Information

*
*
*
*
(e.g. MD, RN, CCM, RPh. If none, enter N/A)
*
*
*
*
*
*

This Satellite Symposium is not endorsed by Optum Health Education and is not part of the accredited activity or directly affiliated with the Medical Director and Clinician Leadership Forum. Sponsor reserves the right to refuse or limit attendance.

If you have questions regarding the Satellite Symposium, please email moreinfo@optumhealtheducation.com.